Department of Cardiology, Yeditepe University Hospital, Icerenkoy Mah. Hastahane Sok. 4, 34752, Istanbul, Turkey.
Centre of Postgraduate Medical Education, Department of Cardiology, Grochowski Hospital, 01-809, Warsaw, Poland.
Europace. 2024 Jul 2;26(7). doi: 10.1093/europace/euae164.
Prior case series showed promising results for cardioneuroablation in patients with vagally induced atrioventricular blocks (VAVBs). We aimed to examine the acute procedural characteristics and intermediate-term outcomes of electroanatomical-guided cardioneuroablation (EACNA) in patients with VAVB.
This international multicentre retrospective registry included data collected from 20 centres. Patients presenting with symptomatic paroxysmal or persistent VAVB were included in the study. All patients underwent EACNA. Procedural success was defined by the acute reversal of atrioventricular blocks (AVBs) and complete abolition of atropine response. The primary outcome was occurrence of syncope and daytime second- or advanced-degree AVB on serial prolonged electrocardiogram monitoring during follow-up. A total of 130 patients underwent EACNA. Acute procedural success was achieved in 96.2% of the cases. During a median follow-up of 300 days (150, 496), the primary outcome occurred in 17/125 (14%) cases with acute procedural success (recurrence of AVB in 9 and new syncope in 8 cases). Operator experience and use of extracardiac vagal stimulation were similar for patients with and without primary outcomes. A history of atrial fibrillation, hypertension, and coronary artery disease was associated with a higher primary outcome occurrence. Only four patients with primary outcome required pacemaker placement during follow-up.
This is the largest multicentre study demonstrating the feasibility of EACNA with encouraging intermediate-term outcomes in selected patients with VAVB. Studies investigating the effect on burden of daytime symptoms caused by the AVB are required to confirm these findings.
先前的病例系列研究表明,心脏神经消融术对迷走神经诱导的房室传导阻滞(VAVB)患者有较好的效果。我们旨在研究电解剖引导心脏神经消融术(EACNA)治疗 VAVB 患者的急性手术特点和中期结果。
这项国际多中心回顾性研究纳入了 20 个中心的数据。纳入的患者为有症状的阵发性或持续性 VAVB。所有患者均接受 EACNA 治疗。手术成功定义为房室阻滞(AVB)的急性逆转和阿托品反应的完全消除。主要结局是在随访期间连续长时间心电图监测时发生晕厥和白天二度或三度房室传导阻滞。共 130 例患者接受了 EACNA 治疗。96.2%的病例在急性手术中获得成功。在中位数为 300 天(150,496)的随访期间,17/125(14%)例急性手术成功的患者发生了主要结局(9 例出现 AVB 复发,8 例出现新晕厥)。有和无主要结局的患者的手术医生经验和使用心外膜迷走神经刺激相似。心房颤动、高血压和冠状动脉疾病的病史与较高的主要结局发生率相关。仅有 4 例有主要结局的患者在随访期间需要植入起搏器。
这是最大的多中心研究,证明了在选定的 VAVB 患者中,EACNA 具有可行性,并取得了令人鼓舞的中期结果。需要研究对 AVB 引起的白天症状负担的影响,以证实这些发现。